Singapore’s GIC invests in German branded medicines platform Cheplapharm

Cheplapharm AG, an international platform for branded medicines, has announced raising €550 million (about $543 million) in structured investment from Singapore sovereign wealth fund GIC and Atlantic Park. Atlantic Park…
Read More